Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities GLUE - Monte Rosa Therapeutics, Inc.
98.9 M
LAST VALUE
119.82%
2 YEAR CAGR
45.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR